ATE524191T1 - Topische pharmazeutische zusammensetzungen für die vagina - Google Patents

Topische pharmazeutische zusammensetzungen für die vagina

Info

Publication number
ATE524191T1
ATE524191T1 AT07013448T AT07013448T ATE524191T1 AT E524191 T1 ATE524191 T1 AT E524191T1 AT 07013448 T AT07013448 T AT 07013448T AT 07013448 T AT07013448 T AT 07013448T AT E524191 T1 ATE524191 T1 AT E524191T1
Authority
AT
Austria
Prior art keywords
pharmaceutical compositions
vagina
topical pharmaceutical
topical
rhatany
Prior art date
Application number
AT07013448T
Other languages
English (en)
Inventor
Pierro Francesco Di
Original Assignee
Velleja Res Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Velleja Res Srl filed Critical Velleja Res Srl
Application granted granted Critical
Publication of ATE524191T1 publication Critical patent/ATE524191T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT07013448T 2006-07-20 2007-07-09 Topische pharmazeutische zusammensetzungen für die vagina ATE524191T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT001421A ITMI20061421A1 (it) 2006-07-20 2006-07-20 Composizioni farmaceutiche topiche vaginali

Publications (1)

Publication Number Publication Date
ATE524191T1 true ATE524191T1 (de) 2011-09-15

Family

ID=38872008

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07013448T ATE524191T1 (de) 2006-07-20 2007-07-09 Topische pharmazeutische zusammensetzungen für die vagina

Country Status (5)

Country Link
EP (1) EP1880727B1 (de)
AT (1) ATE524191T1 (de)
DK (1) DK1880727T3 (de)
IT (1) ITMI20061421A1 (de)
NO (1) NO20073757L (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20130072211A (ko) * 2010-05-18 2013-07-01 인데나 에스.피.에이 부인과 질환 치료를 위한 조성물
EP3294073B1 (de) 2015-05-11 2022-08-10 Mybiotics Pharma Ltd Systeme und verfahren zur züchtung eines biofilms von probiotischen bakterien auf festen partikeln zur kolonisation von bakterien im darm
DE202015106259U1 (de) * 2015-11-10 2016-11-11 Tina Ströer Neuartiger Hygieneartikel
SG11201810428PA (en) 2016-05-25 2018-12-28 Mybiotics Pharma Ltd Composition and methods for microbiota therapy

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1172185B (it) * 1981-12-21 1987-06-18 Serono Ist Farm Composizione particolarmente per la vande vaginali
US20040071679A1 (en) * 2002-10-15 2004-04-15 Claudio De Simone Identifying and treating vaginal infections

Also Published As

Publication number Publication date
NO20073757L (no) 2008-01-21
EP1880727A3 (de) 2010-03-24
EP1880727B1 (de) 2011-09-14
ITMI20061421A1 (it) 2008-01-21
EP1880727A2 (de) 2008-01-23
DK1880727T3 (da) 2011-11-28

Similar Documents

Publication Publication Date Title
AR114143A2 (es) Formulaciones de comprimidos revestidos
CL2016002589A1 (es) Uso del compuesto genz-112638 (eliglustat), inhibidor de glucosilceramida sintasa, en el tratamiento de la enfermedad de gaucher y enfermedad de fabry (divisional de solicitud 201201348).
EA200701029A1 (ru) Новая композиция для облегчения человеческих родов
MX2009007254A (es) Composiciones de tableta en tableta.
MX2010007936A (es) Anticuerpo anti-nr-10 y su uso.
CR20120167A (es) Conjugados de niacina y ácidos grasos y sus usos
BRPI0820997A2 (pt) Comprimidos de desintegração oral compreendendo difenidramina.
CO6440531A2 (es) 2-acetamido-5-aril-1,2,4-triazolonas sustituidas y su uso
DOP2007000102A (es) Arilimidazolonas y ariltriazolona sustituidas asi como su uso
PA8770101A1 (es) Amidas de 4-aril-1,4-dihidro-1, 6-naftiridina sustituidas y su uso
BR112012010057A2 (pt) ácido 3-fenilpropiônico substituído e sua aplicação.
AR064830A1 (es) Composiciones para el cuidado oral que comprenden un extracto de hippophae
GT200600109A (es) Derivados de acido pirimidincarboxilico y su uso
WO2010030598A3 (en) Pharmaceutical formulations comprising pemetrexed
CL2007001724A1 (es) Uso de un estrogeno para el tratamiento de enfermedades, condiciones o sintomas asociados con niveles deficientes de estrogenos en una mujer; composicion farmaceutica que comprende unidades de dosificacion diarias de hemidrato de estradiol > 0,75 y 1
DOP2007000043A (es) Derivados de cromanol sustituidos y su uso
BRPI0815821A2 (pt) Composições e métodos que empregam antagonistas nmda para alcançar um efeito poupador de anestésico.
BRPI0918876A2 (pt) composições para a profilaxia e tratamento de doença dermatológica/mucosa, e suas utilizações
CR10092A (es) Nuevos derivados de furopirimidina aciclicos sustituidos y su uso
SV2006002384A (es) Pirazolo piridinas sustituidas, composiciones que las contienen, procedimiento de fabricacion y utilizacion
WO2007083190A3 (en) Water insoluble helichrysum extract, process for preparing the same and uses thereof
ATE524191T1 (de) Topische pharmazeutische zusammensetzungen für die vagina
ATE531715T1 (de) 1,3-dihydro-2h-pyrroloä3.2-büpyridin-2-onderiva e,deren herstellung und deren therapeutische verwendungen
HN2007000505A (es) Analogos de pirazol
DK1911455T3 (da) Topiske, vaginale farmaceutiske sammensætninger

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties